OBJECTIVE: To study the analgesic effects of naringenin on chronic constriction injury (CCI) model of neuropathic pain. METHODS: After inducing of neuropathic pain by CCI, treatment with 25 and 50 mg/kg of naringenin and 10 mg/kg of pregabalin was given. Rats were evaluated for behavioral tests using Hargreaves apparatus for thermal hyperalgesia, pin prick test for tactile mechanical hyperalgesia and cold water-induced allodynia on days 0, 3, 5, 7, 14 and 21. At the end of study, oxidative stress parameters were measured. RESULTS: Naringenin showed ameliorating action against CCI-induced neuropathic pain in all the tested models. Also, naringenin attenuated the elevated levels of lipid peroxidation and nitric oxide, and restored the level of reduced glutathione. CONCLUSION: The results of the present investigation suggest that naringenin exhibits analgesic effect in sciatic nerve injury model.
OBJECTIVE: To study the analgesic effects of naringenin on chronic constriction injury (CCI) model of neuropathic pain. METHODS: After inducing of neuropathic pain by CCI, treatment with 25 and 50 mg/kg of naringenin and 10 mg/kg of pregabalin was given. Rats were evaluated for behavioral tests using Hargreaves apparatus for thermal hyperalgesia, pin prick test for tactile mechanical hyperalgesia and cold water-induced allodynia on days 0, 3, 5, 7, 14 and 21. At the end of study, oxidative stress parameters were measured. RESULTS:Naringenin showed ameliorating action against CCI-induced neuropathic pain in all the tested models. Also, naringenin attenuated the elevated levels of lipid peroxidation and nitric oxide, and restored the level of reduced glutathione. CONCLUSION: The results of the present investigation suggest that naringenin exhibits analgesic effect in sciatic nerve injury model.
Authors: Allan J C Bussmann; Sergio M Borghi; Tiago H Zaninelli; Telma S Dos Santos; Carla F S Guazelli; Victor Fattori; Talita P Domiciano; Felipe A Pinho-Ribeiro; Kenji W Ruiz-Miyazawa; Antonio M B Casella; Josiane A Vignoli; Doumit Camilios-Neto; Rubia Casagrande; Waldiceu A Verri Journal: Inflammopharmacology Date: 2019-01-05 Impact factor: 4.473
Authors: Daniel P Andersson; Daniel Eriksson-Hogling; Jesper Bäckdahl; Anders Thorell; Patrik Löfgren; Mikael Rydén; Peter Arner; Johan Hoffstedt Journal: Obes Surg Date: 2017-04 Impact factor: 4.129
Authors: Marília F Manchope; Cássia Calixto-Campos; Letícia Coelho-Silva; Ana C Zarpelon; Felipe A Pinho-Ribeiro; Sandra R Georgetti; Marcela M Baracat; Rúbia Casagrande; Waldiceu A Verri Journal: PLoS One Date: 2016-04-05 Impact factor: 3.240
Authors: Azucena I Carballo-Villalobos; María-Eva González-Trujano; Francisco Pellicer; Francisco J López-Muñoz Journal: Biomed Res Int Date: 2016-09-08 Impact factor: 3.411